BB Biotech AG logo

BB Biotech AG (BION)

Market Open
12 Jun, 15:20
SIX SIX
43. 50
CHF
+0.7
+1.6355%
CHF
2.49B Market Cap
9% Div Yield
59,236 Volume
42.8 CHF
Previous Close
Add Transaction
Day Range
43 43.95
Year Range
29 49.65
Want to track BION and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

BB Biotech AG (BION) Statistics

Valuation metrics

Market Cap 2.49B
Enterprise value 2.04B
Trailing P/E (ttm) -8.46
Forward P/E -69.17
PEG ratio 0.03
Price/Sales (ttm) -90.66
Price/Book (mrq) 0.9
Enterprise Value/Revenue -77.24
Enterprise Value/EBITDA -

Overview

Shares outstanding 55.15M
Float -
Shares short -
% Held by insiders 0%
% Held by institutions 0.18%
Average volume (10 days) 63.44K
Average volume (90 days) 96.59K

Price summary

52-Week low 29
52-Week high 49.65
Beta 0.63
50-Day moving average 43.94
200-Day moving average 45.41

Dividends and splits

Forward annual dividend rate 9
Forward annual dividend yield 0.1982%
Trailing annual dividend rate 2.25
Trailing annual dividend yield 0.0517%
5-Year annual dividend yield 5.65%
Payout ratio -0.35
Dividend Date 25 Mar 2026
Ex-Dividend Date 23 Mar 2026
Last split factor 5:1
Last split Date 29 Mar 2016

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026

Profitability

Profit margin 10.64%
Operating margin 1.72%

Operational effectiveness

Return on assets -0.11%
Return on equity -0.12%

Income Statement

Revenue (ttm) 616.88M
Revenue per share (ttm) -0.48
Quarterly revenue growth (yoy) 13.11%
Gross profit (ttm) 616.88M
EBITDA -
Net income to common (ttm) 797.69M
Diluted EPS (ttm) -5.14
Quarterly earnings growth (yoy) -1.28%

Balance Sheet

Total cash (mrq) 2.64B
Total cash per share (mrq) 6.5
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 336.03%
Book value per share (mrq) 48.07

Cash Flow

Cash flow statement 393.7M
Levered free cash flow (LFCF) 2.24B